Cellectis SA (CLLS)
3.21
-0.20
(-5.73%)
USD |
NASDAQ |
Aug 24, 16:00
3.21
0.00 (0.00%)
After-Hours: 20:00
Cellectis Total Assets (Quarterly) : 267.36M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 267.36M |
| March 31, 2026 | 289.19M |
| December 31, 2025 | 331.48M |
| September 30, 2025 | 343.04M |
| June 30, 2025 | 353.97M |
| March 31, 2025 | 364.09M |
| December 31, 2024 | 392.55M |
| September 30, 2024 | 395.88M |
| June 30, 2024 | 407.15M |
| March 31, 2024 | 354.46M |
| December 31, 2023 | 334.27M |
| September 30, 2023 | 209.70M |
| June 30, 2023 | 227.67M |
| March 31, 2023 | 251.41M |
| December 31, 2022 | 261.22M |
| September 30, 2022 | 279.58M |
| June 30, 2022 | 320.88M |
| March 31, 2022 | 347.19M |
| December 31, 2021 | 382.08M |
| September 30, 2021 | 412.89M |
| June 30, 2021 | 457.56M |
| March 31, 2021 | 442.71M |
| December 31, 2020 | 469.47M |
| Date | Value |
|---|---|
| September 30, 2020 | 484.96M |
| June 30, 2020 | 472.70M |
| March 31, 2020 | 471.14M |
| December 31, 2019 | 467.47M |
| September 30, 2019 | 480.48M |
| June 30, 2019 | 505.32M |
| March 31, 2019 | 511.94M |
| December 31, 2018 | 500.84M |
| September 30, 2018 | 519.80M |
| June 30, 2018 | 534.07M |
| March 31, 2018 | 324.05M |
| December 31, 2017 | 332.88M |
| September 30, 2017 | 350.48M |
| June 30, 2017 | 327.66M |
| March 31, 2017 | 326.13M |
| December 31, 2016 | 331.64M |
| September 30, 2016 | 353.07M |
| June 30, 2016 | 358.16M |
| March 31, 2016 | 358.55M |
| December 31, 2015 | 370.50M |
| September 30, 2015 | 337.25M |
| June 30, 2015 | 342.37M |
| March 31, 2015 | 364.91M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| DBV Technologies SA | -- |
| Akari Therapeutics Plc | 38.62M |
| EDAP TMS SA | 74.55M |
| Autolus Therapeutics Plc | 493.23M |
| Evaxion AS | 19.38M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 226.30M |
| Shareholders Equity (Quarterly) | 41.07M |
| Debt to Equity Ratio | 2.539 |
| Current Ratio | 1.366 |
| Net Debt Paydown Yield | 0.30% |